DEFERASIROX 360 MG TABLET

DEFERASIROX
$1.5659per EA

Strength

360 mg/1

NDC

62332041230

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DEFERASIROX

Approval Type

Generic (ANDA)

FDA Application

ANDA211824

On Market Since

11/21/2019

Pharmacological Classes

Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inducers
Iron Chelating Activity
Iron Chelator

Price History

1W

0.0%

1M

-4.7%

3M

+23.5%

6M

+23.5%

1Y

+10.1%

3Y

-20.5%

5Y

N/A

All

-25.6%